FMC Corp
NYSE:FMC

Watchlist Manager
FMC Corp Logo
FMC Corp
NYSE:FMC
Watchlist
Price: 12.97 USD -6.76% Market Closed
Market Cap: 1.6B USD

FMC Corp
Investor Relations

In the dynamic world of agriculture and chemicals, FMC Corporation stands out as a key player, weaving a narrative that intertwines innovation with tradition. Originating as an industrial equipment company in 1883, FMC has evolved substantially, focusing now on delivering sustainable crop protection, and plant health solutions to farmers. Specializing in the development and distribution of insecticides, herbicides, and fungicides, FMC leverages cutting-edge technology and chemistry. This enables it to enhance agricultural productivity while adhering to growing environmental standards. By investing in research and development, FMC aims to address the pressing challenges of global food security, guiding farmers worldwide to increase crop yields through effective and efficient means.

The company’s revenue stream predominantly flows from the sale of its products directly to distributors and retailers, who in turn supply them to farmers. FMC’s approach not only boosts productivity in farm operations globally but also fosters continuous collaboration with the agricultural community. By maintaining close ties with its customers, FMC ensures they receive tailored solutions that adapt to varying climates and crop demands. By balancing its internal capabilities with external partnerships, FMC Corporation strategically positions itself in the market for sustainable growth, deftly catering to the intricate demands of modern agriculture while enhancing shareholder value.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 30, 2025
AI Summary
Q3 2025

Sales Miss & Headwinds: Q3 sales were well below expectations, down sharply due to ongoing credit constraints in Latin America and intense price competition from generics, especially in Brazil and Argentina.

India Business Drag: GAAP net sales dropped 49% YoY to $542 million, largely due to major inventory and write-down actions ahead of the planned sale of the India business.

EBITDA & EPS Growth (Ex-India): Excluding India, adjusted EBITDA grew 17% YoY and adjusted EPS rose 30%, both just above the midpoint of guidance, thanks to cost controls and a better product mix.

Lowered Guidance: Full-year revenue, EBITDA, EPS, and free cash flow guidance were all cut; free cash flow is now expected between negative $200 million and $0.

Dividend Slashed: Quarterly dividend reduced by over 85% to $0.08/share to preserve cash for debt reduction.

Cost & Restructuring Initiatives: Accelerated cost cuts and a strategic review of manufacturing footprint are underway, with more production being shifted to lower-cost sources.

India Sale Progress: Sale process for the India business is advancing with strong buyer interest and a current book value of $450 million.

Debt & Leverage: Net debt increased; all free cash flow beyond the downsized dividend will go to repaying debt.

Key Financials
Revenue
$542 million
Revenue excluding India
$961 million
Adjusted EBITDA
$236 million
Adjusted EBITDA Margin
25%
Adjusted EPS
$0.89
Free Cash Flow
-$233 million (Q3); -$789 million year-to-date
Dividend per Share
$0.08 per quarter
Net Debt
$4.0 billion
Gross Debt
$4.5 billion
Q4 Revenue (guidance, ex-India)
$1.12–$1.22 billion
Q4 Adjusted EBITDA (guidance)
$265–$305 million
Q4 Adjusted EPS (guidance)
$1.36–$1.40
Gross Debt to EBITDA
5x
Net Debt to EBITDA
4.5x
Dividend Funding Need (2026)
$40 million
India Business Fair Market Value
$450 million
Interest Expense (2025 guidance)
$230–$240 million
Depreciation and Amortization (2025 guidance)
$170–$180 million
Effective Tax Rate (2025 guidance)
12%–14%
Earnings Call Recording
Other Earnings Calls

Management

Dr. Pierre R. Brondeau Ph.D.
CEO & Non-Executive Chairman of the Board
No Bio Available
Ms. Jacqueline D. Scanlan
Executive VP & Chief HR Officer
No Bio Available

Contacts

Address
PENNSYLVANIA
PHILADELPHIA
2929 Walnut St
Contacts
+12152996668.0
www.fmc.com